VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $66,172,000 | +22255.4% | 2,846,096 | +13867.9% | 0.10% | +9900.0% |
| Q4 2016 | $296,000 | -40.8% | 20,376 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $500,000 | +48.8% | 20,376 | +22.2% | 0.00% | 0.0% |
| Q2 2016 | $336,000 | -17.6% | 16,671 | +7.6% | 0.00% | 0.0% |
| Q1 2016 | $408,000 | -72.4% | 15,495 | +133.1% | 0.00% | -80.0% |
| Q2 2015 | $1,477,000 | -97.1% | 6,648 | -97.4% | 0.01% | -96.9% |
| Q1 2015 | $50,610,000 | +40.7% | 255,110 | +1.5% | 0.16% | +31.5% |
| Q4 2014 | $35,962,000 | +99.1% | 251,272 | +82.4% | 0.12% | +79.7% |
| Q3 2014 | $18,064,000 | +49.4% | 137,773 | +44.0% | 0.07% | +53.3% |
| Q2 2014 | $12,089,000 | -53.4% | 95,655 | -51.5% | 0.04% | -52.1% |
| Q1 2014 | $25,963,000 | -57.6% | 197,282 | -62.2% | 0.09% | -61.9% |
| Q4 2013 | $61,253,000 | +55.1% | 521,971 | +37.8% | 0.25% | +30.7% |
| Q3 2013 | $39,500,000 | +47.7% | 378,817 | +22.1% | 0.19% | +25.2% |
| Q2 2013 | $26,743,000 | – | 310,214 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |